buena suerte :-)
BOB Bank of Brainchip
Totally agree, we keep talking about getting more but are putting it on hold, and when things calm down (Globally) we hope do some travelling
and then !!!!! who knows
BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
Slymeat
Move on, nothing to see.
buena suerte :-)
BOB Bank of Brainchip
No exacting figures ..... But our CEO Sean Hehir commented with gusto .. " watch the financials" so I would say ..... Substantial !! but who knows?
Yes, but a solution to global warming.I have mixed feelings.
Do I want the massive share price increase because you are right about Apple or do I want to avoid having to put up with your head getting so big it cuts out light from the Sun reaching Earth because you called it two calendar years ago.
What a dilemma.
FF
AKIDA BALLISTA
DingoBorat
Slim
It was more along the lines of..
"Our hires will increase to around 100 total employees, so increasing our costs, but our increasing revenues, should match this"
So our outgoings, should remain fairly even, by the end of the year, but with a greatly increased ability, in all areas that matter, technology and sales.
They are building the foundations, for a Global tech giant, so breakeven and profit, may not come as quickly as we like, but the Company, will be growing and making big strides.
At least that's my take on what he said and what I hope to occur.
Keep in mind, that companys like Amazon and Tesla, only became profitable, in the last couple of years, but their share prices/market caps, were already huge by then..
wilzy123
Founding Member
Sirod69
bavarian girl ;-)
thought he was being a smart arse and "dip stick" as such. As my reply said................MY BAD!
Cant even blame the keyboard for the miss placed decimal point, so its my bad eyesight to blame!
Y
WELL,
what are points if you can have fries
equanimous
Norse clairvoyant shapeshifter goddess
David holland
Regular
What do you think mate, next yrs AGM What's the predicted share price
Sirod69
bavarian girl ;-)
A.I. gurus are leaving Big Tech to work on buzzy new start-ups
Artificial intelligence workers are quitting top jobs at companies like Google, Meta, OpenAI and DeepMind and joining a new breed of start-ups.
Last edited:
Falling Knife
Regular
Short term punters ??? how so?? Do they have the power to do 70 Mil Shorts in two tranches since 31 May ??? don't think so!
TOTAL shorts 98 Mil as of Tuesday 07 June 2022.
View attachment 8919
View attachment 8920
Gotta know the GAME being played!
Yak52
The math dosent add up in relation to what happens from here:
we have trades of 106 million in the last 8 trading days (Todays not included and this is comsec data only)
If sales continue like this for another 8 days that gets us to 23rd June (mon 13th PH on ASX)
ASX 200 inclusion is set for Monday 20th, potentially buyers lining up COB Friday 17th.
How much do these fundies need to match the index?
Where is the volume going to come from?
not my stash.
When they start buying back to cover shorts in the midst of the ASX 200 inclusion the pressure and FOMO will add to the buying volume, we have seen it before in runs on BRN SP.
Its a snowball waiting to start rolling IMO
Last edited:
Frank Zappa
Regular
Don’t forget nose and ears .
Rise from the ashes
Regular
Ok that really seals the deal
eye test first thing on Tuesday. I was like look at those two strange looking faces what are they
upon further inspection they're doggo paws.Thought it was some type of hairy EMU breed
Last edited:
buena suerte :-)
BOB Bank of Brainchip
Funny asOk that really seals the deal eye test first thing on Tuesday. I was like look at those two strange looking faces what are they
Learning
Learning to the Top 🕵♂️
May be this is old, but what is this?
Its above my pay grade.
Are they testing different neural networks? To see what best for their application?
Learning
Its above my pay grade.
Are they testing different neural networks? To see what best for their application?
WO2021195563A1 - Arrangements for digital marking and reading of items, useful in recycling - Google Patents
Images depicting items in a waste flow on a conveyor belt are provided to two analysis systems. The first system processes images to decode digital watermark payload data found on certain of the items (e.g., plastic containers). This payload data is used to look up corresponding attribute...
patents.google.com
Learning
Last edited:
Sirod69
bavarian girl ;-)
VOM ENIAC ZUM BRAINIAC: NEUROMORPHES COMPUTING
Die Nachbildung der Struktur und Funktion des menschlichen Gehirns verspricht enorme Fortschritte: im Gesundheitswesen, bei KI und der Entwicklung ungeahnter Technologien.
D
Deleted member 118
Guest
Can only seem to get that done overseas lolDon’t forget nose and ears .
buena suerte :-)
BOB Bank of Brainchip
June 10th, 2022 | 10:47 CEST
Apple is entering the healthcare market and unearthing a treasure trove of sensitive patient data that can improve the lives of many people around the world. The latest updates in hardware and software enable close monitoring of body vital signs and medication intake. A boon for families with, for example, parents with heart disease. To keep such highly sensitive data in safe places, Australian company BrainChip has an IP on the market that allows self-learning AI systems to stay right on the chip, secure as Fort Knox, free from the cloud. The exact opposite is bringing Amazon strong share price gains. Its web services help the share price jump rapidly.
time to read: 6 minutes | Author: Juliane Zielonka
ISIN: APPLE INC. | US0378331005 , BRAINCHIP HOLDINGS LTD | AU000000BRN8 , AMAZON.COM INC. DL-_01 | US0231351067
Author
Born in Bielefeld, she studied German, English and psychology. The emergence of the Internet in the early '90s led her from university to training in graphic design and marketing communications. After years of agency work in corporate branding, she switched to publishing and learned her editorial craft at Hubert Burda Media.
About the author
Apple users are very familiar with the artificial intelligence called "Siri." The built-in control assistant with the friendly female voice is activated via voice control and can execute light applications on cue. Like a virtual assistant, Siri can open applications on the iPhone, save notes, and call contacts.
Apple Health users are used to recording their steps. The Apple Watch already measures blood oxygen and heart rate and automatically switches to exercise records as soon as the motion sensors register a steady step rhythm. The built-in AI activates an emergency call system if a fall occurs and the Apple Watch wearer stops moving altogether.
The next innovative step especially helps people with chronic diseases to take their medication regularly. In the US, users can also receive alerts about potential drug interactions when they upload a new prescription. This tool is ideal for families who want to share medication data along with other health data. Thinking further, this creates logistics chains with mail-order pharmacies or medication delivery services.What at first glance seems like commercialization in the secondary healthcare market has the potential to make a breakthrough in digital health.
Apple has been supplying hospitals and doctors-in-training in the B2B segment for years. Future doctors are getting used to the iOS interface and its handling, so building a digital ecosystem around health data will only be a matter of time. The tech giant also announced that a new feature to detect atrial fibrillation will be available in watchOS 9. This is a heart condition that, if detected early, can be well treated.
The new FDA-approved feature will allow users to closely track their heart rhythm and determine if signs of atrial fibrillation are present. And once a Siri gently whispers to move more, the more Siri learns from each user through body vital signs, the more likely it is to give digital AI a chance in terms of personal behavior change.
Even though tech is still shaken in the stock market, Tim Cook's vision of Apple becoming the health brand and pioneer in digital health is becoming a reality. Apple offers investors a good opportunity to capture the healthcare market through AI and Big Data.
Artificial intelligence with self-learning capabilities is the business of BrainChip Holdings. Its business model is based on licensing the intellectual property of this AI to achieve the greatest possible scale and reach.
BrainChip's flagship product Akida™ (ISIN AU0000BRN8) is the first neuromorphic processor IP on the market that mimics the human brain. Neuromorphic computers use architectures and principles similar to information processing in the brain. IT systems based on electronic models of neural circuits are called "neuromorphic." AI is executed locally on the chip, significantly reducing latency. By running processes directly on the chip, Akida is independent of cloud providers, which increases data privacy and security of applications. Cloud freedom allows data to be processed in place." Michael Dell, who has been very successful in the technology industry for some time, estimates that about 10% of all computing and data takes place on the chip. By 2025, he expects at least 75%. That is a significant shift," explains CEO Sean Hehir.
Wherever the greatest possible data security is required, technology like Akida is used. Be it in the healthcare sector with highly sensitive patient and drug data, cybersecurity technology companies or autonomous driving and electric mobility worldwide. Large corporations, intermediaries and SMEs form the target groups of BrainChip Holdings. The Australian company has already established partnerships with, for example, the Japanese semiconductor manufacturer MegaChips, which generally already develops highly complex AI and machine learning systems in-house. MegaChips focuses on automotive and industrial equipment growth areas, such as 5G communications infrastructure and factory automation. In addition, BrainChip serves mid-sized companies that want to deploy AI but only have a small developer team of three or four employees. This is where chip manufacturers or developers come in, and BrainChip provides them with its licensing model. The growth potential for neuromorphic AI systems that do not require the cloud is enormous. More information on the go-to-market strategy can be found here.
If platform services like Netflix were to acquire their own servers, this could have a negative impact on profit forecasts because the international service would mean that they would have to build their own data centers worldwide. The "everything from a single source" model, or turnkey solution in technical jargon, continues to send Amazon's share price hurtling upward. In the first quarter of 2022, the AWS division grew revenue by 37% to EUR 17.2 billion. With a market share of 33%, Amazon is the leader in the cloud business, ahead of Microsoft and Alphabet.
With the artificial intelligence Alexa, Amazon succeeded in entering countless private households. However, the AI based on voice control has a disadvantage: through the connection to the Amazon Cloud, it becomes a privacy spy because Alexa listens to everything. One would rather have a device with an Akida chip for pure local data processing.
Tracking and collecting health data from the Quantified Self movement is coming of age. Apple in Cupertino succeeds in taking the next growth step in the huge health market. With the latest updates, Apple users are able to measure highly sensitive patient data to maintain and improve health themselves. For such purposes, Australian company BrainChip Holdings has developed a neuromorphic processor IP named Akida, which companies can use as a licensing model. The big advantage is that the local edge solution keeps the data in place. Security is one of the most important purchasing decisions for large corporations, especially in times of cyberattacks. On the other hand, Amazon is growing through its cloud business as it relieves platform-based companies such as Netflix, Airbnb and Facebook of needing to purchase data centers. The AWS division grew 37% in Q1 2022.
AI DRIVING GROWTH IN TECH STOCKS: APPLE, BRAINCHIP, AMAZON
- TECHNOLOGY
- CHIPS
- AI
Apple is entering the healthcare market and unearthing a treasure trove of sensitive patient data that can improve the lives of many people around the world. The latest updates in hardware and software enable close monitoring of body vital signs and medication intake. A boon for families with, for example, parents with heart disease. To keep such highly sensitive data in safe places, Australian company BrainChip has an IP on the market that allows self-learning AI systems to stay right on the chip, secure as Fort Knox, free from the cloud. The exact opposite is bringing Amazon strong share price gains. Its web services help the share price jump rapidly.
time to read: 6 minutes | Author: Juliane Zielonka
ISIN: APPLE INC. | US0378331005 , BRAINCHIP HOLDINGS LTD | AU000000BRN8 , AMAZON.COM INC. DL-_01 | US0231351067
TABLE OF CONTENTS:
- APPLE - SCALING INTO THE AI-DRIVEN HEALTHCARE MARKET
- BRAINCHIP - IP AS A BUSINESS MODEL FOR LEARNING AI SYSTEMS
- AMAZON - CLOUD BUSINESS GROWTH DRIVER
Full interview
Author
JULIANE ZIELONKA
Born in Bielefeld, she studied German, English and psychology. The emergence of the Internet in the early '90s led her from university to training in graphic design and marketing communications. After years of agency work in corporate branding, she switched to publishing and learned her editorial craft at Hubert Burda Media.
About the author
TAG CLOUD
- BIOTECHNOLOGY
- TECHNOLOGY
- CHIPS
- AI
- DIGITIZATION
- CAMPING
- INVESTMENTS
- NEOBROKER
- OIL
- GREENHYDROGEN
- CHEMICALS
- MINING
- GOLD
- ELECTROMOBILITY
- ARMAMENTS
- COPPER
- ECOMMERCE
- VACCINATION
- LITHIUM
- COMMODITIES
SHARES CLOUD
- BIONTECH SE SPON. ADRS 1
- NERVGEN PHARMA CORP
- VALNEVA SE EO -_15
- APPLE INC.
- BRAINCHIP HOLDINGS LTD
- AMAZON.COM INC. DL-_01
- PATHFINDER VENTURES INC
- DEUTSCHE BANK AG NA O.N.
- WALLSTREET:ONLINE INH ON
- ALIBABA GR.HLDG SP.ADR 8
- NOVAVAX INC. DL-_01
- NEL ASA NK-_20
- BP PLC DL-_25
- BASF SE NA O.N.
- SATURN OIL + GAS INC.
- RHEINMETALL AG
- BYD CO. LTD H YC 1
- TRIUMPH GOLD CORP.
- MERCEDES-BENZ GROUP AG
- ALTECH ADV.MAT. NA O.N.
APPLE - SCALING INTO THE AI-DRIVEN HEALTHCARE MARKET
At this year's Worldwide Developers Conference, Apple (ISIN US0378331005) unveiled a new tool designed to facilitate medication tracking and other health-related functions. The "Medications" feature in the Health app is available on both the Apple Watch and the iPhone. It allows users to manage their medications, vitamins and supplements. The camera can scan a pill bottle and help you take your medication on time.Apple users are very familiar with the artificial intelligence called "Siri." The built-in control assistant with the friendly female voice is activated via voice control and can execute light applications on cue. Like a virtual assistant, Siri can open applications on the iPhone, save notes, and call contacts.
Apple Health users are used to recording their steps. The Apple Watch already measures blood oxygen and heart rate and automatically switches to exercise records as soon as the motion sensors register a steady step rhythm. The built-in AI activates an emergency call system if a fall occurs and the Apple Watch wearer stops moving altogether.
The next innovative step especially helps people with chronic diseases to take their medication regularly. In the US, users can also receive alerts about potential drug interactions when they upload a new prescription. This tool is ideal for families who want to share medication data along with other health data. Thinking further, this creates logistics chains with mail-order pharmacies or medication delivery services.What at first glance seems like commercialization in the secondary healthcare market has the potential to make a breakthrough in digital health.
Apple has been supplying hospitals and doctors-in-training in the B2B segment for years. Future doctors are getting used to the iOS interface and its handling, so building a digital ecosystem around health data will only be a matter of time. The tech giant also announced that a new feature to detect atrial fibrillation will be available in watchOS 9. This is a heart condition that, if detected early, can be well treated.
The new FDA-approved feature will allow users to closely track their heart rhythm and determine if signs of atrial fibrillation are present. And once a Siri gently whispers to move more, the more Siri learns from each user through body vital signs, the more likely it is to give digital AI a chance in terms of personal behavior change.
Even though tech is still shaken in the stock market, Tim Cook's vision of Apple becoming the health brand and pioneer in digital health is becoming a reality. Apple offers investors a good opportunity to capture the healthcare market through AI and Big Data.
BRAINCHIP - IP AS A BUSINESS MODEL FOR LEARNING AI SYSTEMS
Artificial intelligence like Siri or Amazon's Alexa need memory to archive their learning. On the one hand, it needs semiconductors to create the physical space. On the other hand, learning successes are created by programmed algorithms that are able to continue changing themselves. This process is comparable to the human brain. The grey matter in the head is the physical location for the millions of nerve cells, which, depending on the training and application, continually reconnect and provide the appropriate output in their neuronal impulses.Artificial intelligence with self-learning capabilities is the business of BrainChip Holdings. Its business model is based on licensing the intellectual property of this AI to achieve the greatest possible scale and reach.
BrainChip's flagship product Akida™ (ISIN AU0000BRN8) is the first neuromorphic processor IP on the market that mimics the human brain. Neuromorphic computers use architectures and principles similar to information processing in the brain. IT systems based on electronic models of neural circuits are called "neuromorphic." AI is executed locally on the chip, significantly reducing latency. By running processes directly on the chip, Akida is independent of cloud providers, which increases data privacy and security of applications. Cloud freedom allows data to be processed in place." Michael Dell, who has been very successful in the technology industry for some time, estimates that about 10% of all computing and data takes place on the chip. By 2025, he expects at least 75%. That is a significant shift," explains CEO Sean Hehir.
Wherever the greatest possible data security is required, technology like Akida is used. Be it in the healthcare sector with highly sensitive patient and drug data, cybersecurity technology companies or autonomous driving and electric mobility worldwide. Large corporations, intermediaries and SMEs form the target groups of BrainChip Holdings. The Australian company has already established partnerships with, for example, the Japanese semiconductor manufacturer MegaChips, which generally already develops highly complex AI and machine learning systems in-house. MegaChips focuses on automotive and industrial equipment growth areas, such as 5G communications infrastructure and factory automation. In addition, BrainChip serves mid-sized companies that want to deploy AI but only have a small developer team of three or four employees. This is where chip manufacturers or developers come in, and BrainChip provides them with its licensing model. The growth potential for neuromorphic AI systems that do not require the cloud is enormous. More information on the go-to-market strategy can be found here.
AMAZON - CLOUD BUSINESS GROWTH DRIVER
In contrast to BrainChip's model, top dog Amazon (ISIN US0231351067) continues to focus on expanding its Amazon Web Services (AWS) in the cloud. E-commerce merchants, who care more about their business than their end customers' data security, are using the many tools available in the cloud-based offering. Amazon Web Services consists of more than 200 services, including telephony and machine learning. Companies that use AWS are Netflix, Facebook and Airbnb. They value the smooth flow of services for their own scaling.If platform services like Netflix were to acquire their own servers, this could have a negative impact on profit forecasts because the international service would mean that they would have to build their own data centers worldwide. The "everything from a single source" model, or turnkey solution in technical jargon, continues to send Amazon's share price hurtling upward. In the first quarter of 2022, the AWS division grew revenue by 37% to EUR 17.2 billion. With a market share of 33%, Amazon is the leader in the cloud business, ahead of Microsoft and Alphabet.
With the artificial intelligence Alexa, Amazon succeeded in entering countless private households. However, the AI based on voice control has a disadvantage: through the connection to the Amazon Cloud, it becomes a privacy spy because Alexa listens to everything. One would rather have a device with an Akida chip for pure local data processing.
Tracking and collecting health data from the Quantified Self movement is coming of age. Apple in Cupertino succeeds in taking the next growth step in the huge health market. With the latest updates, Apple users are able to measure highly sensitive patient data to maintain and improve health themselves. For such purposes, Australian company BrainChip Holdings has developed a neuromorphic processor IP named Akida, which companies can use as a licensing model. The big advantage is that the local edge solution keeps the data in place. Security is one of the most important purchasing decisions for large corporations, especially in times of cyberattacks. On the other hand, Amazon is growing through its cloud business as it relieves platform-based companies such as Netflix, Airbnb and Facebook of needing to purchase data centers. The AWS division grew 37% in Q1 2022.
Wags
Regular
Our new puppy "WAGS" graduating puppy school, just before we got covid. Her has been the best company whilst sick.Ok that really seals the deal eye test first thing on Tuesday. I was like look at those two strange looking faces what are they
Attachments
Similar threads
